134 related articles for article (PubMed ID: 26384592)
1. Structural insights into the intertwined dimer of fyn SH2.
Huculeci R; Garcia-Pino A; Buts L; Lenaerts T; van Nuland N
Protein Sci; 2015 Dec; 24(12):1964-78. PubMed ID: 26384592
[TBL] [Abstract][Full Text] [Related]
2. Structural Characterization of Monomeric/Dimeric State of p59
Huculeci R; Kieken F; Garcia-Pino A; Buts L; van Nuland N; Lenaerts T
Methods Mol Biol; 2017; 1555():257-267. PubMed ID: 28092037
[TBL] [Abstract][Full Text] [Related]
3. 1H, 13C and 15N backbone and side-chain chemical shift assignment of the Fyn SH2 domain and its complex with a phosphotyrosine peptide.
Huculeci R; Buts L; Lenaerts T; van Nuland NA
Biomol NMR Assign; 2011 Oct; 5(2):181-4. PubMed ID: 21298565
[TBL] [Abstract][Full Text] [Related]
4. Purification, crystallization and preliminary X-ray diffraction analysis of the Fyn SH2 domain and its complex with a phosphotyrosine peptide.
Huculeci R; Buts L; Lenaerts T; van Nuland NA; Garcia-Pino A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Mar; 68(Pt 3):359-64. PubMed ID: 22442244
[TBL] [Abstract][Full Text] [Related]
5. Chemical shift assignments of the partially deuterated Fyn SH2-SH3 domain.
Kieken F; Loth K; van Nuland N; Tompa P; Lenaerts T
Biomol NMR Assign; 2018 Apr; 12(1):117-122. PubMed ID: 29224116
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
7. Dynamically Coupled Residues within the SH2 Domain of FYN Are Key to Unlocking Its Activity.
Huculeci R; Cilia E; Lyczek A; Buts L; Houben K; Seeliger MA; van Nuland N; Lenaerts T
Structure; 2016 Nov; 24(11):1947-1959. PubMed ID: 27692963
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the phosphotyrosine binding pocket of Fyn SH2 domain led to the identification of novel SH2 superbinders.
Li S; Zou Y; Zhao D; Yin Y; Song J; He N; Liu H; Qian D; Li L; Huang H
Protein Sci; 2021 Mar; 30(3):558-570. PubMed ID: 33314411
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
[TBL] [Abstract][Full Text] [Related]
10. SH3-SH2 domain orientation in Src kinases: NMR studies of Fyn.
Ulmer TS; Werner JM; Campbell ID
Structure; 2002 Jul; 10(7):901-11. PubMed ID: 12121645
[TBL] [Abstract][Full Text] [Related]
11. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
[TBL] [Abstract][Full Text] [Related]
12. Quantifying information transfer by protein domains: analysis of the Fyn SH2 domain structure.
Lenaerts T; Ferkinghoff-Borg J; Stricher F; Serrano L; Schymkowitz JW; Rousseau F
BMC Struct Biol; 2008 Oct; 8():43. PubMed ID: 18842137
[TBL] [Abstract][Full Text] [Related]
13. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
[TBL] [Abstract][Full Text] [Related]
14. Surface Loops in a Single SH2 Domain Are Capable of Encoding the Spectrum of Specificity of the SH2 Family.
Liu H; Huang H; Voss C; Kaneko T; Qin WT; Sidhu S; Li SS
Mol Cell Proteomics; 2019 Feb; 18(2):372-382. PubMed ID: 30482845
[TBL] [Abstract][Full Text] [Related]
15. Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacity.
Weir ME; Mann JE; Corwin T; Fulton ZW; Hao JM; Maniscalco JF; Kenney MC; Roman Roque KM; Chapdelaine EF; Stelzl U; Deming PB; Ballif BA; Hinkle KL
FEBS Lett; 2016 Apr; 590(8):1042-52. PubMed ID: 27001024
[TBL] [Abstract][Full Text] [Related]
16. SAP couples Fyn to SLAM immune receptors.
Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
[TBL] [Abstract][Full Text] [Related]
17. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
18. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
[TBL] [Abstract][Full Text] [Related]
19. Superbinder SH2 domains act as antagonists of cell signaling.
Kaneko T; Huang H; Cao X; Li X; Li C; Voss C; Sidhu SS; Li SS
Sci Signal; 2012 Sep; 5(243):ra68. PubMed ID: 23012655
[TBL] [Abstract][Full Text] [Related]
20. Measurement of dissociation rate of biomolecular complexes using CE.
Yang P; Mao Y; Lee AW; Kennedy RT
Electrophoresis; 2009 Feb; 30(3):457-64. PubMed ID: 19148904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
